Prognostic value of ctDNA in triple-negative breast cancer
ctDNA and residual cancer burden after neoadjuvant systemic therapy are independently prognostic in triple-negative breast cancer patients
ctDNA and residual cancer burden after neoadjuvant systemic therapy are independently prognostic in triple-negative breast cancer patients